-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AF1bC3uXVot8I5HEpGaci9P/9ieZw/Sy5hb/xCPLf326Q+xZnsMwafhaPxNWdOYS N8LdkVC1QU0c5V/f2hvjvA== 0001144204-08-009493.txt : 20080214 0001144204-08-009493.hdr.sgml : 20080214 20080214161417 ACCESSION NUMBER: 0001144204-08-009493 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071231 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080214 EFFECTIVENESS DATE: 20080214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 08615830 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 v103232_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2007 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue, 17th Floor -------------------------------------------- New York, NY 10065-8029 -------------------------------------------- Form 13F File Number: 28-10519 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-339-5633 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. February 14, 2008 - -------------------------- --------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 97 ----------- Form 13F Information Table Entry Value: 1,335,615 ----------- (thousands) List of Other Included Managers: None Baker Brothers Form 13F 12-31-07
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY Name of Issuer CUSIP (x1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ---------------------------- ------- ------- ------- --- ---- ---------- -------- ---- ------ ---- Acadia Pharmaceuticals Inc. COM 004225108 24,468 2,210,279 SH SOLE 2,210,279 Acorda Therapeutics COM 00484M106 25,196 1,147,390 SH SOLE 1,147,390 Adolor Corp. COM 00724X102 1,173 254,921 SH SOLE 254,921 Alkermes COM 01642T108 3,047 195,457 SH SOLE 195,457 Allos Therapeutics Inc. COM 019777101 54,984 8,741,480 SH SOLE 8,741,480 Alsius Corp. COM 021211107 240 64,850 SH SOLE 64,850 Altus Pharmaceuticals Inc. COM 02216N105 210 40,477 SH SOLE 40,477 Amicus Therapeutics COM 03152W109 12,240 1,138,619 SH SOLE 1,138,619 Amylin Pharmaceuticals Inc. COM 032346108 6,652 179,771 SH SOLE 179,771 Anadys Pharmaceuticals Inc. COM 03252Q408 141 87,500 SH SOLE 87,500 Anesiva Inc. COM 21872P501 6,915 1,382,977 SH SOLE 1,382,977 AP Pharma COM 00202J203 2,394 1,515,152 SH SOLE 1,515,152 Aradigm Corp. COM 038505301 152 100,000 SH SOLE 100,000 Ardea Biosciences Inc. COM 03969P107 49,592 3,241,313 SH SOLE 3,241,313 Ardea Biosciences Inc. PFD A 03969P206 11,109 726,065 SH SOLE 726,065 Arena Pharmaceuticals Inc. COM 040047102 219 27,930 SH SOLE 27,930 Array Biopharma Inc. COM 04269X105 2,205 261,928 SH SOLE 261,928 Atherogenics Inc. COM 047439104 10 25,357 SH SOLE 25,357 Autoimmune Inc. COM 052776101 43 26,100 SH SOLE 26,100 Auxilium COM 05334D107 66,570 2,219,745 SH SOLE 2,219,745 Biocryst Pharmaceuticals Inc. COM 09058V103 36,576 5,918,411 SH SOLE 5,918,411 Biomarin Pharmaceutical Inc. COM 09061G101 16 453 SH SOLE 453 Cerus Corp. COM 157085101 215 33,048 SH SOLE 33,048 Chelsea Therapeutics COM 163428105 8,360 1,137,481 SH SOLE 1,137,481 Coley Pharmaceutical Group Inc. COM 19388P106 5,087 635,855 SH SOLE 635,855 Critical Therapeutics Inc. COM 22674T105 1,432 1,127,481 SH SOLE 1,127,481 Cubist COM 229678AC1 3,681 179,450 SH SOLE 179,450 Curis Inc. COM 231269101 26 26,800 SH SOLE 26,800 Cyclacel Pharmaceuticals COM 23254L108 1,424 259,886 SH SOLE 259,886 Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% PFD CONV EX 23254L207 454 95,500 SH SOLE 95,500 Cytokinetics Inc. COM 23282W100 8,097 1,711,864 SH SOLE 1,711,864 Decode Genetics COM 2435686104 790 214,733 SH SOLE 214,733 Emergent Biosolutions COM 29089Q105 1,225 242,089 SH SOLE 242,089 Epix Pharmaceuticals COM 26881Q309 592 150,248 SH SOLE 150,248 Exelisis COM 30161Q104 256 29,660 SH SOLE 29,660 Genelabs Technologies Inc. COM 368706206 959 755,179 SH SOLE 755,179 Genomic Health Inc. COM 37244C101 108,515 4,793,090 SH SOLE 4,793,090 Halozyme Therapeutics Inc. COM 40637H109 6,855 964,088 SH SOLE 964,088 Icagen Inc. COM 45104P104 127 75,468 SH SOLE 75,468 Idera Pharmaceuticals Inc. COM 45168K108 21,050 1,606,854 SH SOLE 1,606,854 Immunogen Inc. COM 45253H101 1,159 279,178 SH SOLE 279,178 Immunomedics, Inc. COM 452907108 290 125,000 SH SOLE 125,000 Incyte Corp. COM 45337C102 73,845 7,347,790 SH SOLE 7,347,790 Indevus Pharmaceuticals COM 454072109 4,871 700,794 SH SOLE 700,794 Infinity Pharmaceuticals Inc. COM 45665G303 818 85,651 SH SOLE 85,651 Inspire COM 457733103 2,713 453,706 SH SOLE 453,706 Intermune Inc. COM 45884X103 21,420 1,606,930 SH SOLE 1,606,930 Isis Pharmaceuticals Inc. COM 464330109 297 18,859 SH SOLE 18,859 Kosan COM 50064W107 8,129 2,258,059 SH SOLE 2,258,059 Ligand Pharmaceuticals Inc. CL B 53220K207 185 38,224 SH SOLE 38,224 Map Pharmaceuticals COM 56509R108 263 15,000 SH SOLE 15,000 Metabasis Therapeutics Inc. COM 59101M105 6,980 2,334,466 SH SOLE 2,334,466 Micromet COM 59509C105 4,577 2,221,614 SH SOLE 2,221,614 Myriad Genetics Inc. COM 62855J104 17,292 372,519 SH SOLE 372,519 Neopharm Inc. COM 640919106 26 44,438 SH SOLE 44,438 Neose Technologies Inc. COM 640522108 2,392 2,235,590 SH SOLE 2,235,590 Neurogen Corp. COM 64124E106 17,757 5,147,078 SH SOLE 5,147,078 Novo-Nordisk COM 670100205 26,453 403,806 SH SOLE 403,806 Onyx Inc. COM 683399109 6,989 125,650 SH SOLE 125,650 Optimer Pharmaceuticals COM 68401H104 8,943 1,277,500 SH SOLE 1,277,500 OSI Pharmaceuticals COM 671040103 5,411 111,553 SH SOLE 111,553 Pharmacyclics Inc. COM 716933106 469 323,598 SH SOLE 323,598 Pharmasset Inc. COM 71715N106 2,894 214,365 SH SOLE 214,365 Pharmion Corp. COM 71715B409 173,044 2,752,844 SH SOLE 2,752,844 Pharmion Corp. @35 Exp. 6/21/08 CALL 9EDOOK138 1,463 500 SH CALL SOLE 500 Pharmion Corp. @50 Exp. 6/21/08 CALL 9EQ1ZYU02 1,489 922 SH CALL SOLE 922 Poniard Pharmaceuticals Inc. COM 732449301 166 37,755 SH SOLE 37,755 Pozen Inc. COM 73941U102 12,467 1,038,943 SH SOLE 1,038,943 Regeneron COM 78556F107 1,694 70,132 SH SOLE 70,132 Salix Pharmaceuticals, Inc. COM 795435106 7,152 907,553 SH SOLE 907,553 Seattle Genetics Inc. COM 812578102 108,444 9,512,589 SH SOLE 9,512,589 Siga Technologies Inc. COM 826917106 2,907 943,888 SH SOLE 943,888 Sirtris Pharmaceuticals Inc. COM 82968A105 190 13,843 SH SOLE 13,843 Spectrum Pharmaceuticals Inc. COM 84763A108 1,663 611,261 SH SOLE 611,261 Sunesis Pharmaceuticals Inc. COM 867328502 2,621 1,317,039 SH SOLE 1,317,039 Supergen COM 868059106 4,160 1,139,849 SH SOLE 1,139,849 Symyx Technologies, Inc. COM 87155S108 2,503 325,973 SH SOLE 325,973 Synvista Therapeutics, Inc. CONV PFD B 871992103 18,480 8,400,000 SH SOLE 8,400,000 Tapestry Pharmaceuticals Inc. COM 876031204 600 2,000,000 SH SOLE 2,000,000 Targacept COM 87611R306 1,139 137,950 SH SOLE 137,950 Threshold Pharma COM 885807107 1,200 2,263,600 SH SOLE 2,263,600 Torreypines Therapeutics COM 89235K105 468 204,465 SH SOLE 204,465 Trimeris Inc. COM 896263100 24,159 3,461,175 SH SOLE 3,461,175 Vertex Pharmaceuticals Inc. COM 92532F100 9,835 423,393 SH SOLE 423,393 Vertex Pharmaceuticals Inc. @20 EXP 1/19/2008 CALL 9EQ1NI5I3 1,729 4,736 SH CALL SOLE 4,736 Via Pharmaceuticals COM 92554T103 252 102,881 SH SOLE 102,881 Vion Pharm COM 927624AA4 82 148,118 SH SOLE 148,118 Viropharma Inc. COM 928241108 57,401 7,229,413 SH SOLE 7,229,413 Xenoport Inc. COM 98411C100 43,106 771,406 SH SOLE 771,406 Alexion Pharmaceuticals Notes 1.375% 2/01/2012 CONV BONDS 015351AF6 20,242 8,300,000 PRN SOLE 8,300,000 Amylin Pharmaceuticals Notes 2.5% 4/15/11 CONV BONDS 032346AD0 11,326 8,980,000 PRN SOLE 8,980,000 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 CONV BONDS 09061GAD3 22,215 12,000,000 PRN SOLE 12,000,000 Biomarin Pharmaceuticals Notes 2.5% 3/29/2013 CONV BONDS 09061GAC5 41,711 18,569,000 PRN SOLE 18,569,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAE2 18,640 18,972,000 PRN SOLE 18,972,000 Intermune Inc Notes .25% 3/01/2011 CONV BONDS 45884XAC7 7,916 8,500,000 PRN SOLE 8,500,000 Medarex Inc Notes 2.25% 5/15/2011 CONV BONDS 583916AG6 14,550 13,472,000 PRN SOLE 13,472,000 Viropharma Inc. Notes 2.0% 3/15/2017 CONV BONDS 928241AH1 33,131 45,000,000 PRN SOLE 45,000,000
-----END PRIVACY-ENHANCED MESSAGE-----